Your browser is no longer supported. Please, upgrade your browser.
Settings
SNOA [NASD]
Sonoma Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.52 Insider Own1.07% Shs Outstand2.34M Perf Week-21.31%
Market Cap14.52M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.07M Perf Month-27.88%
Income-5.30M PEG- EPS next Q- Inst Own6.80% Short Float12.00% Perf Quarter-27.52%
Sales14.50M P/S1.00 EPS this Y4.40% Inst Trans-2.14% Short Ratio0.18 Perf Half Y-44.76%
Book/sh4.89 P/B0.88 EPS next Y- ROA-32.80% Target Price- Perf Year-36.09%
Cash/sh2.50 P/C1.73 EPS next 5Y- ROE-65.30% 52W Range4.63 - 15.19 Perf YTD-40.50%
Dividend- P/FCF- EPS past 5Y43.50% ROI-57.00% 52W High-71.56% Beta0.78
Dividend %- Quick Ratio3.80 Sales past 5Y14.70% Gross Margin28.80% 52W Low-6.70% ATR0.35
Employees13 Current Ratio4.40 Sales Q/Q-36.20% Oper. Margin-33.30% RSI (14)25.61 Volatility7.56% 6.64%
OptionableNo Debt/Eq0.07 EPS Q/Q-161.00% Profit Margin-37.90% Rel Volume0.09 Prev Close4.68
ShortableYes LT Debt/Eq0.00 EarningsNov 15 BMO Payout- Avg Volume1.35M Price4.32
Recom2.00 SMA20-21.02% SMA50-23.45% SMA200-36.30% Volume123,784 Change-7.69%
Nov-15-21 08:00AM  
Nov-09-21 07:00AM  
Oct-15-21 07:44AM  
07:00AM  
Sep-30-21 12:50PM  
Sep-29-21 03:37AM  
Sep-28-21 02:37PM  
12:05PM  
07:00AM  
Aug-20-21 12:19PM  
Aug-19-21 01:19PM  
09:46AM  
08:23AM  
07:00AM  
06:44AM  
Aug-16-21 04:15PM  
Jul-15-21 03:51PM  
Jul-14-21 07:56PM  
Mar-31-21 04:10PM  
Mar-11-21 09:00PM  
Mar-09-21 08:15PM  
Mar-04-21 05:03PM  
Feb-19-21 05:07PM  
Feb-16-21 05:30PM  
Feb-15-21 03:45PM  
Feb-10-21 12:50PM  
Feb-08-21 11:07AM  
Feb-02-21 08:00AM  
Feb-01-21 03:47PM  
Jan-28-21 04:30PM  
Jan-27-21 02:30PM  
Jan-18-21 06:00PM  
Jan-14-21 11:45AM  
Jan-11-21 05:30PM  
Dec-24-20 04:07PM  
Dec-23-20 12:40AM  
Dec-19-20 11:35PM  
Dec-17-20 06:17PM  
04:10PM  
Dec-16-20 04:47PM  
Dec-12-20 08:08PM  
Dec-11-20 10:37AM  
08:11AM  
Dec-10-20 04:10PM  
Dec-09-20 11:30PM  
Dec-08-20 03:47PM  
Dec-07-20 08:13PM  
Dec-05-20 09:20PM  
Dec-02-20 02:15PM  
09:25AM  
Dec-01-20 01:15PM  
Nov-30-20 09:00PM  
08:46PM  
Nov-29-20 07:45AM  
Nov-27-20 10:17AM  
10:00AM  
Nov-26-20 01:00PM  
Nov-25-20 11:20PM  
08:26PM  
11:00AM  
09:46AM  
Nov-24-20 08:47PM  
01:41PM  
01:33PM  
10:36AM  
Nov-20-20 04:21PM  
Sep-18-20 07:30AM  
Sep-17-20 04:05PM  
Sep-10-20 07:20AM  
Sep-09-20 04:10PM  
Aug-14-20 04:59PM  
Jul-29-20 07:32AM  
Jul-28-20 04:05PM  
Jul-10-20 05:00PM  
May-30-20 11:59AM  
May-29-20 05:08PM  
10:10AM  
08:20AM  
May-28-20 04:30PM  
May-26-20 04:57PM  
Apr-28-20 09:08AM  
Feb-28-20 07:28AM  
Feb-27-20 05:00PM  
Feb-14-20 05:30PM  
Jan-29-20 11:31AM  
Jan-24-20 10:44AM  
Jan-23-20 04:43PM  
Nov-29-19 04:42PM  
Nov-26-19 10:10AM  
Nov-25-19 07:54PM  
Nov-14-19 06:00PM  
Oct-29-19 02:57PM  
Oct-01-19 05:09PM  
Aug-28-19 11:28AM  
Aug-13-19 05:35PM  
Jul-12-19 09:00AM  
Jul-09-19 07:11AM  
Jul-08-19 04:03PM  
Jun-19-19 04:05PM  
May-21-19 04:05PM  
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; SebuDerm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and Ceramax, a Lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as Loyon for the management of skin scaling. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products designed to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH and MicrocynVS, which are HOCl-based solutions designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Pediacyn, Epicyn, Gramaderm, and Microdacyn for dermatoses, scar management, and acne; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.